WORKSHOP ITALIANO Lunedì 4 Novembre e Martedi 5 Novembre
Head & Neck Forum
10 invitations to win for the congress in Florence!
Abstract submission is closed now. The deadline expired on June 28.
Abstracts must be submitted before June 28, 2013.
An abstract is considered to be received only if the author has received a formal acknowledgement of receipt from EUROGIN.
When submitting an abstract, please indicate if the abstract is intended for:
- oral presentation
- poster presentation
- no preference
General Conditions for Submission of Abstracts
- Submission of an abstract implies the commitment that the presenting author registers for the Eurogin 2013 congress and that financial resources to attend are available.
- Abstracts must be submitted and presented in ENGLISH.
- Abstracts should be prepared as a WORD document in accordance with the editing instructions below, and sent by email to the EUROGIN organizing committee at the following address:
Abstracts that do not comply with the editing instructions will not be considered.
- For Free Communications or Poster sessions, only ONE abstract can be submitted per person (presenter).
- Original scientific material is welcome and preference is given to recent findings not published yet at the date of the congress.
- Abstracts will be peer reviewed and classified by experts in one of the categories (topics) listed; they will be allocated for oral or poster presentation. Authors who do not wish to be considered for oral presentation are requested to indicate this when submitting. However, please note, that the Scientific Committee will make the final decision for the mode of presentation.
- The final decision of the Scientific Committee will be announced before July 19, 2013.
- Authors agree that their abstract will be published in an Abstract Book which will be provided to all registered participants of the congress.
- All accepted abstract authors will receive confirmation by email. Please do not forget to indicate your correct email address and telephone number when submitting your abstract.
- Most accepted abstracts will be allocated for poster presentation. Detailed technical instructions will be made available to the authors in due time.
- All accepted abstracts will be published in the final abstract book of the conference.
Abstract Editing Instructions
- Format: WORD file.
- Maximum number of characters: 2,200, not counting spaces, but including title and accreditations.
- Use Arial font size 11
- The title must be written in UPPER CASE (capitals) and bold; (keep it brief, clearly indicating the nature of the investigation. It should not exceed 2 lines).
- Please avoid complex mathematical formulae.
- Abstracts should be structured in three sections, clearly mentioned as such: objectives – methods - conclusions.
- Authors should be listed by their LAST NAME (family name) followed by initials of the first name only (do not include full first names). ONE author must be identified as PRESENTER by underlining of his name.
- Give professional address for all authors: name of hospital, unit or laboratory, city and country in lower case. No other indications are to be given. If different affiliations, please use numbers.
- Do not indent spaces on the first line of each paragraph. Abstracts should be typed single spaced, with no space between paragraphs. Use international standards for scientific articles.
- Only standard abbreviations may be used without definition. Data must be given in units widely used in literature.
- Only essential references should be included and put in brackets at the end of the abstract: numbers in the text may refer to them.
- Drugs must be identified by their generic names.
For review purposes, abstracts are classified according to the following list. Select only 1 topic that best characterizes your abstract:
- Viral and molecular biology
- Epidemiology and natural history
- HPV prophylactic vaccines: clinical aspects
- HPV prophylactic vaccines: basic science
- HPV therapeutic vaccines
- HPV testing
- Molecular markers
- Screening methods
- Liquid based cytology
- Automation in cytology
- New technologies
- Diagnostic procedures
- Cervical neoplasia
- Vaginal neoplasia
- Vulvar diseases and neoplasia
- Anal neoplasia
- Oral HPV infection
- HPV and oropharynx / Head and neck cancer
- HPV and associated skin diseases
- HPV and other neoplasia
- Genital warts
- Sexually transmitted diseases and HIV infection
- Conventional therapies
- New treatments - Immunotherapy
- Economics and modelling
- Advocacy, acceptability and psychology
- Health education
- Low resource settings